Moreover, the addition of WNT inhibitors abrogated the inhibitory effect of siALKBH5 on the growth of primary CRC organoids (Fig. S13D), indicating that effectiveness of targeting ALKBH5 requires activated WNT signaling. Here, ALKBH5 is linked to colorectal carcinoma.